(Q44344935)

2 December 2017

title

Effects of liver disease on the disposition of the opioid antagonist nalmefene (English)

1 reference

2 December 2017

0 references

1

1 reference

2 December 2017

Matzke GR

2

1 reference

2 December 2017

Schade R

series ordinal

3

1 reference

2 December 2017

Dixon R

series ordinal

4

1 reference

2 December 2017

Rabinovitz M

series ordinal

5

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Clinical Pharmacology & Therapeutics

2 December 2017

published in

1 reference

2 December 2017

volume

61

1 reference

2 December 2017

issue

1

1 reference

2 December 2017

page(s)

15-23

1 reference

Comparison of potency and duration of action of nalmefene and naloxone.

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Chlordiazepoxide and oxazepam disposition in cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Normal disposition of oxazepam in acute viral hepatitis and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Effects of aging and liver disease on disposition of lorazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

The metabolism and bioavailability of morphine in patients with severe liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Antagonism of morphine-induced respiratory depression with nalmefene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Effectiveness and safety of intravenous nalmefene for emergency department patients with suspected narcotic overdose: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Duration of antagonistic effects of nalmefene and naloxone in opiate-induced sedation for emergency department procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

The effect of renal insufficiency and hemodialysis on the pharmacokinetics of nalmefene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Clinical pharmacokinetics in patients with liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Major drug interactions: effect of liver disease, alcohol, and malnutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Transection of the oesophagus for bleeding oesophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Assay of Antipyrine and Its Primary Metabolites in Plasma, Saliva and Urine by High-Performance Liquid Chromatography and Some Preliminary Results in Man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Nalmefene: radioimmunoassay for a new opioid antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

The effects of age and chronic liver disease on the elimination of temazepam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Paracetamol metabolism in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Acetaminophen in chronic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Glucuronidation of oxazepam is not spared in patients with hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

Hepatic extraction of morphine is impaired in cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9236%2897%2990178-8

10.1016/S0009-9236(97)90178-8

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference